Disruptive Approaches To Accelerate Drug Discovery and Development (Part 2)
Posted in Archive
| Tagged AI / data analytics / healthtech / informatics, Analysis, Analytical chemistry, Animal models, Assay development optimisation & technology, Automation / robotics, Biomarkers, Business, Cell therapy, Cellular & Molecular biology, Cellular assays, Chemical engineering, Chemistry, Clinical trials, Combinatorial chemistry, Computational chemistry, Drug development, Drug discovery, Drug repositioning, Drug targets, Enabling technologies, Gene therapy, Genetics / genomics, Genomics, High Content Screening, High throughput screening, Immunology, In Silico Biology, Lead discovery, Lead optimisation, Molecular medicine, Organic chemistry, Orphan drugs, Patent Law, Pathology, Pharmacogenomics, Pharmacology, Protein chemistry / Proteomics, Regulatory, RNA, Screening, Stem cells, System biology, Systems biology, Target validation, Therapeutics, Toxicology, Translational, Translational chemistry
